
The FDA granted 510(k) clearance March 16 to a laser system (LensAR Laser System, LensAR Inc.) for anterior capsulotomy and lens fragmentation during cataract surgery.
The FDA granted 510(k) clearance March 16 to a laser system (LensAR Laser System, LensAR Inc.) for anterior capsulotomy and lens fragmentation during cataract surgery.
You and your patients are invited to play nine holes of miniature golf at the Transitions Mini-Golf Championship, an online golf game that is part of Transitions Optical?s Improve Your Vision, Improve Your Game consumer education initiative designed to connect seeing well to performing well and healthy sight to having a healthy, quality life.
Bausch + Lomb and Technolas Perfect Vision GmbH (TPV) plan to globally distribute a femtosecond laser capable of performing both cataract and refractive procedures on one platform.
A line of electronically focusing prescription eyewear (emPower!, PixelOptics) formally was introduced at Vision Expo East in New York City.
SynergEyes Inc. will continue to be a major sponsor of the National Keratoconus Foundation, a patient outreach and education program of the non-profit organization Discovery Eye Foundation, with a contribution of $20,000.
Soft contact lens manufacturer CooperVision has unveiled a new brand positioning and visual identity with the goal of better communicating the organization?s values.
Larry Amdahl has joined independent ophthalmic product development firm Ora Inc. as director of clinical operations for dry eye.
The meeting of the Asia-Pacific Academy of Ophthalmology taking place this week included a ?Challenges of Eye Hospital Management in the 21st Century: A Global Perspective? symposium on Tuesday.
Think About Your Eyes, a public awareness campaign designed to educate Americans about the importance of vision health and comprehensive eye exams, has launched new television and radio advertisements in the Atlanta, Chicago, Cincinnati, Denver, Houston, Los Angeles, New York, Portland, OR, and Sacramento, CA, markets.
Coming soon to a theater, cable television station, or network television station near you: five commercials touting the benefits of a proprietary implantable contact lens ([ICL] Visian ICL, STAAR Surgical Co.) over contact lenses and glasses.
Nutraceuticals provider ScienceBased Health (SBH) and optics manufacturer Hoya Surgical Optics (HSO) have formed a partnership.
Transitions Optical Inc. and partners held the third annual Transitions Championship PGA Tour event March 17 to 20 at the Innisbrook Resort and Golf Club.
Prevent Blindness America has designated March as Workplace Vision Month by in an effort to educate corporations and their employees on the importance of vision health. Tell employers in your community that they can participate in the non-profit organization?s Healthy Eyes Vision Wellness Program at no charge.
Kemin has launched a national marketing campaign to promote its brand of lutein (FloraGLO) and educate consumers about the role lutein plays in maintaining healthy vision.
A new one-piece IOL (Tecnis Toric 1-Piece IOL, Abbott Medical Optics) has been introduced for use in Europe in patients with cataracts. Unlike conventional IOLs, the new implant can correct pre-existing corneal astigmatism.
Robert Ritch, MD, FACS, will receive the Jose Rizal International Medal from the Asia Pacific Academy of Ophthalmology during the March 20 opening ceremony of the organization?s annual meeting in Sydney, Australia.
The FDA has notified TearLab Corp. that the agency cannot approve the company?s Clinical Laboratory Improvement Amendments (CLIA) waiver categorization application for its osmolarity system (TearLab Osmolarity System) based on the data submitted, according to the company
STAAR Surgical Co. and Ellex Australia have entered into an agreement that makes Ellex the exclusive distributor of STAAR IOLs in Australia. Ellex will market a line of refractive lenses (Visian ICL), IOLs for cataract patients, and related products. As part of the distribution agreement, Ellex also will purchase the current inventory of product in Australia for about $400,000.
The board of directors of Allergan has reappointed David E.I. Pyott as president, effective March 27. Pyott? who previously served as president from 1998 until 2006 ? also will continue to serve Allergan in his current roles as chairman of the board and chief executive officer. Pyott's role as president is not an interim position, and Allergan does not plan to name a new president.
Attendees at International Vision Expo East who are looking for ?the next big thing? in eyewear and technology ? and who also would like a chance to win $500 ? are invited to stop by the show?s New Product Gallery. The New Product Gallery is designed to give attendees a first-hand look at the frames, accessories, and technologies being introduced at the show.
In our field, there can't be bad days.
Dramatic changes are coming to the way Medicare will pay physicians for their services, but savvy practices that voluntarily adopt the reporting procedures can financially benefit from incentives offered now.
Ophthalmologists are reacting with shock and anger after a bill giving optometrists authority to perform certain laser surgical procedures was through the Kentucky state legislature and signed into law in just 3 weeks.
A recently introduced line of reusable safety blades can help to minimize the risk of sharps injuries in the operating room.
Keratoprosthesis is a viable therapeutic option for many patients with end-stage corneal diseases who are poor candidates for traditional corneal transplantation.
Eyewear presentation should include planned communications that help your patients understand the value of their purchases.
Two events are changing the landscape of IOLs: the advancement and acceptance of toric IOLs and the aging of patients who have undergone previous LASIK so that they now need cataract surgery.
The author reflects, lightheartedly, on our overuse of cliches.
While practices pride themselves on the quality of care they deliver, many of those same practices get low marks for their quality of caring.
No single intervention for inflammatory thyroid eye disease currently provides a cure.